tracheal transplantation
Recently Published Documents


TOTAL DOCUMENTS

99
(FIVE YEARS 14)

H-INDEX

17
(FIVE YEARS 1)

2021 ◽  
pp. 101467
Author(s):  
Tatsuaki Watanabe ◽  
Stephen C. Juvet ◽  
Kristen Boonstra ◽  
Zehong Guan ◽  
Betty Joe ◽  
...  

2021 ◽  
pp. 039139882110259
Author(s):  
Jaime Villalba-Caloca ◽  
Avelina Sotres-Vega ◽  
David M Giraldo-Gómez ◽  
Miguel O Gaxiola-Gaxiola ◽  
Maria C Piña-Barba ◽  
...  

Background: The repair of long-segment tracheal lesions remains an important challenge. Nowdays no predictable and dependable substitute has been found. Decellularized tracheal scaffolds have shown to be a promising graft for tracheal transplantation, since it is non-immunogenic. Objective: Evaluate in vivo decellularized tracheal allografts performance to replace long tracheal segment. Methods: Forty-five swines underwent surgery as follows: Fifteen trachea donors and 30 receptors of decellularized trachea allografts. The receptors were randomly divided in five groups ( n = 6). In groups I and II, donor trachea segment was decellularized by 15 cycles with sodium deoxycholate and deoxyribonuclease, in group II, the allograft was reinforced with external surgical steel wire. Groups, III, IV, and V decellularization was reduced to seven cycles, supplemented with cryopreservation in group IV and with glutaraldehyde in group V. A 10 rings segment was excised from the receptor swine and the decellularized trachea graft was implanted to re-establish trachea continuity. Results: Both decellularization cycles caused decreased stiffness. All trachea receptors underwent euthanasia before the third post-implant week due to severe dyspnea and trachea graft stenosis, necrosis, edema, inflammation, hemorrhage, and granulation tissue formation in anastomotic sites. Histologically all showed total loss of epithelium, separation of collagen fibers, and alterations in staining. Conclusions: Both decellularization techniques severely damaged the structure of the trachea and the extracellular matrix of the cartilage, resulting in a no functional graft, in spite of the use of surgical wire, cryopreservation or glutaraldehyde treatment. An important drawback was the formation of fibrotic stenosis in both anastomosis.


Author(s):  
Eric M. Genden ◽  
Brett A. Miles ◽  
Timothy Harkin ◽  
Samuel DeMaria ◽  
Andrew J. Kaufman ◽  
...  

Author(s):  
Yamato Suzuki ◽  
Hisashi Oishi ◽  
Masahiko Kanehira ◽  
Yasushi Matsuda ◽  
Takashi Hirama ◽  
...  

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Laura Pandolfi ◽  
Roberta Fusco ◽  
Vanessa Frangipane ◽  
Ramona D’Amico ◽  
Marco Giustra ◽  
...  

AbstractBronchiolitis Obliterans Syndrome seriously reduces long-term survival of lung transplanted patients. Up to now there is no effective therapy once BOS is established. Nanomedicine introduces the possibility to administer drugs locally into lungs increasing drug accumulation in alveola reducing side effects. Imatinib was loaded in gold nanoparticles (GNP) functionalized with antibody against CD44 (GNP-HCIm). Lung fibroblasts (LFs) were derived from bronchoalveolar lavage of BOS patients. GNP-HCIm cytotoxicity was evaluated by MTT assay, apoptosis/necrosis and phosphorylated-cAbl (cAbl-p). Heterotopic tracheal transplantation (HTT) mouse model was used to evaluate the effect of local GNP-HCIm administration by Alzet pump. GNP-HCIm decreased LFs viability compared to Imatinib (44.4 ± 1.8% vs. 91.8 ± 3.2%, p < 0.001), inducing higher apoptosis (22.68 ± 4.3% vs. 6.43 ± 0.29; p < 0.001) and necrosis (18.65 ± 5.19%; p < 0.01). GNP-HCIm reduced cAbl-p (0.41 GNP-HCIm, 0.24 Imatinib vs. to control; p < 0.001). GNP-HCIm in HTT mouse model by Alzet pump significantly reduced tracheal lumen obliteration (p < 0.05), decreasing apoptosis (p < 0.05) and TGF-β-positive signal (p < 0.05) in surrounding tissue. GNP-HCIm treatment significantly reduced lymphocytic and neutrophil infiltration and mast cells degranulation (p < 0.05). Encapsulation of Imatinib into targeted nanoparticles could be considered a new option to inhibit the onset of allograft rejection acting on BOS specific features.


2019 ◽  
Vol 57 ◽  
pp. 101244
Author(s):  
Yiqian Li ◽  
Ping Shu ◽  
Liang Tang ◽  
Xiaojun Yang ◽  
Junwei Fan ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document